Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term glioblastoma. Found 12 abstracts

Lu Y, Deng X, Xiao G, Zheng X, Ma L, Huang W. circ_0001730 promotes proliferation and invasion via the miR-326/Wnt7B axis in glioma cells. Epigenomics. 2019 Aug;11(11):1335-52.
Mortazavi SM. Commentary: Geographic Variations in the Incidence of Glioblastoma and Prognostic Factors Predictive of Overall Survival in US Adults from 2004-2013. Frontiers in Aging Neuroscience. 2018 Apr;10:105.   PMCID: PMC5906709
Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, Michael M, Moots PL, Morrison T, Mrugala M, Nabors LB, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK, Vrionis FD, Wen PY. Central Nervous System Cancers. Journal of the National Comprehensive Cancer Network. 2011 Apr;9(4):352-400.   PMCID: not NIH funded
Huang J, Zhang L, Greshock J, Colligon TA, Wang Y, Ward R, Katsaros D, Lassus H, Butzow R, Godwin AK, Testa JR, Nathanson KL, Gimotty PA, Coukos G, Weber BL, Degenhardt Y. Frequent Genetic Abnormalities of the PI3K/AKT Pathway in Primary Ovarian Cancer Predict Patient Outcome. Genes Chromosomes & Cancer. 2011 Aug;50(8):606-18.   PMCID: PMC3110626
Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EE, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Muller T, Ratain MJ, Salgia R. Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer. Journal of Clinical Oncology. 2011 Jul;29(19):2660-6.   PMCID: not NIH funded
Perry JR, Rizek P, Cashman R, Morrison M, Morrison T. Temozolomide Rechallenge in Recurrent Malignant Glioma by Using a Continuous Temozolomide Schedule The "Rescue" Approach. Cancer. 2008 Oct;113(8):2152-7.
Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, Fujikawa K, Bjornsson J, Bernstein J, Henske EP. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer. 1998 Nov 15;83(10):2208-16.
Curran Jr WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. Journal of the National Cancer Institute. 1993 Jan;85(9):704-10.
Curran Jr WJ, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, Corn B, Nelson DF. Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: A report of Radiation Therapy Oncology Group 83-02. Journal of Clinical Oncology. 1993 Jan;11(5):857-62.
Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF. Recursive Partitioning Analysis of Prognostic Factors in 3 Radiation-Therapy Oncology Group Malignant Glioma Trials. Journal of the National Cancer Institute. 1993 May 05;85(9):704-10.
Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, Weinstein AS, Nelson DF. Influence of Location and Extent of Surgical Resection on Survival of Patients with Glioblastoma-Multiforme - Results of 3 Consecutive Radiation-Therapy Oncology Group (Rtog) Clinical- Trials. International Journal of Radiation Oncology Biology Physics. 1993 May 20;26(2):239-44.
Curran WJ, Scott CB, Nelson JS, Weinstein AS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, Powlis WD, Nelson DF. A Randomized Trial of Accelerated Hyperfractionated Radiation- Therapy and Bis-Chlorethyl Nitrosourea for Malignant Glioma - a Preliminary-Report of Radiation-Therapy Oncology Group 83-02. Cancer. 1992 Dec 15;70(12):2909-17.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term glioblastoma

glioblastoma chemotherapy surgery identification temozolomide radiotherapy expression postoperative treatment management normal-tissues beta-catenin hippel-lindau disease phase-ii trial tumor site spinal-cord compression electromagnetic fields circRNAs radiotherapy plus concomitant glioma glioblastoma multiforme extent of resection cancer radiotherapy MGMT brain metastases brain cancer brain radiation-therapy astrocytomas copy number brain neoplasms cell lung-carcinoma renal cell carcinoma angiogenesis therapy medulloblastoma mutations miR-326 average-risk medulloblastoma growth suppressor mobile phones randomized trial adults growth-factor receptor prognostic phase-ii bcnu patient cancer survival sorafenib growth refractory trials ret protooncogene mutations bis-chlorethyl nitrosourea irinotecan epithelial to mesenchymal transition angiomyolipoma multimodality cancer therapy tumor size genetic-linkage tuberous sclerosis gamma-knife surgery met tumorigenesis spinal tumors Wnt7B recurrent malignant glioma bevacizumab tsc1 clinical- carcinoma kinase renal-cell carcinoma comparative genomic hybridization brain tumor astrocytoma GLIOBLASTOMA protein anaplastic astrocytoma heterozygosity METRONOMIC CHEMOTHERAPY NCCN Guidelines malignant glioma PTEN (JNCCN 2011 hyperfractionation tumor cooperative group geographic variations dexamethasone anaplastic gliomas rechallenge 9:352-400) radiation therapy fractionation vegf high-dose NCCN Clinical Practice Guidelines clinical-trials radiotherapy plus bcnu importance chromosome 9q34 carmustine
Last updated on Sunday, July 05, 2020